Amgen’s Approach to AI-Enabled Clinical Development

Source Domain: www.amgen.com

Integration of AI in Drug Development: Amgen is embedding AI into every stage of the drug development process to create a connected capability that bridges Research and Development, from molecule design to global clinical trial execution.
Designing Better Molecules: Marti Head’s team leverages AI-enabled methods to design molecules with intended therapeutic properties from the beginning, speeding up the drug discovery process and enhancing predictive understanding of molecule success.
Designing Smarter Trials via Digital Twins: Amy Xia’s team utilizes patient-level predictive models called digital twins to design more precise and patient-centered clinical trials, especially for complex and rare diseases.
Ensuring Operational Efficiency: Kate Owen’s Global Development Operations leverages AI-powered platforms to drive operational efficiencies and ensure optimal execution of clinical trials, focusing on data oversight, real-time insights, and proactive risk management.

You may have missed